Literature DB >> 8977207

IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses.

T K VanHeyningen1, H L Collins, D G Russell.   

Abstract

The ability of Mycobacterium bovis Calmette-Guérin bacillus-infected bone marrow-derived macrophages to process and present exogenously added Ags to T cells and stimulate their growth and production of IL-2 was examined. The infected macrophages were inhibited in their ability to activate T cells, and this inhibition could be transferred to uninfected macrophages with filtered supernatants from mycobacteria-infected macrophages. The inhibition was not due to decreases in macrophage viability, Ag uptake, or cell surface expression of MHC class II or other accessory molecules necessary for Ag presentation. Other intracellular pathogens such as Listeria monocytogenes and Leishmania mexicana did not induce the soluble inhibitory factor, while Mycobacterium avium strain 101 did, suggesting the factor is specific to infection with mycobacteria. The inhibitory effect was reversed completely by preincubation with neutralizing Abs against IL-6, and rIL-6 partially restored the effect. Approximately 10,000-fold more IL-6 was produced by mycobacteria-infected macrophages compared with uninfected controls. Such sustained levels of IL-6 may account for the immune unresponsiveness apparent in both human and murine mycobacterial disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8977207

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Mycobacterium bovis BCG-infected mice are more susceptible to staphylococcal enterotoxin B-mediated toxic shock than uninfected mice despite reduced in vitro splenocyte responses to superantigens.

Authors:  João A Pedras-Vasconcelos; Yvan Chapdelaine; Renu Dudani; Henk van Faassen; Dean K Smith; Subash Sad
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  The role of B7 molecules in the cell contact-mediated suppression of T cell mitogenesis by immunosuppressive macrophages induced with mycobacterial infection.

Authors:  T Shimizu; C Sano; H Tomioka
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

3.  IFN-gamma induces the erosion of preexisting CD8 T cell memory during infection with a heterologous intracellular bacterium.

Authors:  Renu Dudani; Kaja Murali-Krishna; Lakshmi Krishnan; Subash Sad
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

4.  A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response.

Authors:  Kerry J Welsh; April N Abbott; Shen-An Hwang; Jessica Indrigo; Lisa Y Armitige; Michael R Blackburn; Robert L Hunter; Jeffrey K Actor
Journal:  Microbiology (Reading)       Date:  2008-06       Impact factor: 2.777

Review 5.  Why intracellular parasitism need not be a degrading experience for Mycobacterium.

Authors:  D G Russell; S Sturgill-Koszycki; T Vanheyningen; H Collins; U E Schaible
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

6.  PPE38 modulates the innate immune response and is required for Mycobacterium marinum virulence.

Authors:  Dandan Dong; Decheng Wang; Ming Li; Hui Wang; Jia Yu; Chuan Wang; Jun Liu; Qian Gao
Journal:  Infect Immun       Date:  2011-10-28       Impact factor: 3.441

7.  Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine.

Authors:  I S Leal; B Smedegârd; P Andersen; R Appelberg
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

8.  Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2.

Authors:  Paula Barrionuevo; Juliana Cassataro; M Victoria Delpino; Astrid Zwerdling; Karina A Pasquevich; Clara García Samartino; Jorge C Wallach; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

9.  Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening.

Authors:  Katherine B Hisert; Meghan A Kirksey; James E Gomez; Alexandra O Sousa; Jeffery S Cox; William R Jacobs; Carl F Nathan; John D McKinney
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Putative roles of a proline-glutamic acid-rich protein (PE3) in intracellular survival and as a candidate for subunit vaccine against Mycobacterium tuberculosis.

Authors:  Susmita K Singh; Ruma Kumari; Diwakar K Singh; Sameer Tiwari; Pramod K Singh; Sharad Sharma; Kishore K Srivastava
Journal:  Med Microbiol Immunol       Date:  2013-05-25       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.